GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » e-Therapeutics PLC (LSE:ETX) » Definitions » FCF Yield %

e-Therapeutics (LSE:ETX) FCF Yield % : -19.66 (As of May. 27, 2024)


View and export this data going back to 2007. Start your Free Trial

What is e-Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, e-Therapeutics's Trailing 12-Month Free Cash Flow is £-10.34 Mil, and Market Cap is £52.59 Mil. Therefore, e-Therapeutics's FCF Yield % for today is -19.66%.

The historical rank and industry rank for e-Therapeutics's FCF Yield % or its related term are showing as below:

LSE:ETX' s FCF Yield % Range Over the Past 10 Years
Min: -20.26   Med: -7.52   Max: -1.9
Current: -19.66


During the past 13 years, the highest FCF Yield % of e-Therapeutics was -1.90%. The lowest was -20.26%. And the median was -7.52%.

LSE:ETX's FCF Yield % is ranked worse than
57.79% of 1554 companies
in the Biotechnology industry
Industry Median: -14.415 vs LSE:ETX: -19.66

e-Therapeutics's FCF Margin % for the quarter that ended in Jul. 2023 was -4,371.88%.


e-Therapeutics FCF Yield % Historical Data

The historical data trend for e-Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

e-Therapeutics FCF Yield % Chart

e-Therapeutics Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.44 -20.24 -4.38 -5.08 -8.72

e-Therapeutics Semi-Annual Data
Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.95 -6.54 -8.80 -7.09 -13.78

Competitive Comparison of e-Therapeutics's FCF Yield %

For the Biotechnology subindustry, e-Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


e-Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, e-Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where e-Therapeutics's FCF Yield % falls into.



e-Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

e-Therapeutics's FCF Yield % for the fiscal year that ended in Jan. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-8.221 / 94.309758
=-8.72%

e-Therapeutics's annualized FCF Yield % for the quarter that ended in Jul. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-6.995 * 2 / 101.5344295
=-13.78%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


e-Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


e-Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of e-Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


e-Therapeutics (LSE:ETX) Business Description

Traded in Other Exchanges
Address
4 Kingdom Street, Paddington, London, GBR, W2 6BD
e-Therapeutics PLC is a drug discovery company. Its ambition is to transform the drug discovery process, leveraging its computational network biology platform (drug discovery) to find novel targets to address mechanisms underpinning complex disease. l company activities are carried out in the UK.

e-Therapeutics (LSE:ETX) Headlines